Treatment Patterns and Outcomes Among Patients With Chronic Myeloid Leukemia (CML) in All Lines of Treatment
Clinical trial NCT07188428 · COMPLETED
Trial details
- NCT number
- NCT07188428
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2024-02-27
- Primary completion
- 2024-12-02
- Enrollment
- 2298
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.